News
4don MSN
Hepatitis and fatty liver disease, major causes of chronic liver injury, often present with subtle, easily overlooked ...
US FDA lifts clinical hold on PORTOLA phase 2a trial of Kezar Life Sciences for evaluating zetomipzomib to treat autoimmune hepatitis: South San Francisco, California Friday, July ...
Sana Makbul’s flight from Jodhpur to Mumbai was diverted to Ahmedabad due to a mid-air technical issue, prompting an ...
The Division of Hepatology and Nutrition of the US Food and Drug Administration (FDA) has lifted the partial clinical hold on ...
Emma Mendelssohn, 22, from California, has been battling several chronic illnesses since she was 12, culminating in her ...
The FDA has lifted one of the two clinical holds placed on Kezar Life Sciences’ zetomipzomib, leading the biotech to speculate on whether to reignite another program for the same drug that remains ...
5d
GlobalData on MSNNovartis culls ianalumab in HS after Phase IIb trial failureNovartis is stopping the development of ianalumab in hidradenitis suppurativa (HS) after a Phase IIb proof-of-concept trial ...
Hepatitis remains an important cause of liver disease in Malaysia, although our goal is to eventually eliminate it.
Hepatitis A is a severe liver infection caused by the hepatitis A virus, (HAV), a highly contagious virus that can range in ...
Autoimmune diseases, such as vitiligo, celiac disease and rheumatoid arthritis, are not tied to aluminum exposure from vaccines, according to a nationwide cohort study of approximately 1.2 million ...
6d
News-Medical.Net on MSNAluminum vaccines cleared of long-term health risksFindings from a cohort of 1.2 million children indicate aluminum-adsorbed vaccines do not raise the risk of autism, asthma, ...
In Nigeria, the prevalence among children under five stood at 0.3 per cent, slightly above the 2025 regional target.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results